Start Date
June 30, 2013
Primary Completion Date
June 30, 2017
Cilengitide
2000 mg by vein twice weekly of each 28 day cycle.
Bevacizumab
10 mg/kg by vein on Days 1 and 15 of each 28 day cycle.
Questionnaire
Completion of MD Anderson Symptom Inventory for Brain Tumors (MDASI-BT) at baseline, Day 1 of cycle 2, and at end of treatment visit. Questionnaire should take about 5 minutes to complete.
Collaborators (1)
Brain Tumor Trials Collaborative
OTHER
EMD Serono
INDUSTRY
M.D. Anderson Cancer Center
OTHER